1. Andrews, P.W., Damjanov, I., Simon, D., et al., Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro, Lab. Invest., 1984, vol. 50, pp. 147–162.
2. Andrews, P.W., Damjanov, I., Simon, D., et al., A pluripotent human stem-cell clone isolated from the TERA-2 teratocarcinoma line lacks antigens SSEA-3 and SSEA-4 in vitro, but expresses these antigens when grown as a xenograft tumor, Differentiation, 1985, vol. 29, pp. 127–135.
3. Andrews, P.W., Human teratocarcinomas, Biochim. Biophys. Acta, 1988, vol. 948, pp. 17–36.
4. Brons, I.G.M., Smithers, L.E., Trotter, M.W.B., et al., Derivation of pluripotent epiblast stem cells from mammalian embryos, Nature, 2007, vol. 448, pp. 191–195.
5. Caisander, G., Park, H., Frej, K., et al., Chromosomal integrity maintained in five human embryonic stem cell lines after prolonged in vitro culture, Chromosome Res., 2006, vol. 14, pp. 131–137.